ReP USP - Resultado da busca

Artigo de periodico
Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis (2020)
Leclerc, Jacinthe; Thibault, Magalie; Midiani Gonella, Jennifer; Beaudoin, Claudia; Sampalis, John
Source: Drugs. Unidade: EERP
Subjects: MEDICAMENTO GENÉRICO, CARDIOLOGIA, FÁRMACOS (SISTEMA CARDIOVASCULAR), REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LECLERC, Jacinthe et al. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis. Drugs, v. 80, n. 7, p. 697-710, 2020Tradução . . Disponível em: https://doi.org/10.1007/s40265-020-01296-x. Acesso em: 25 abr. 2026.
APA
Leclerc, J., Thibault, M., Midiani Gonella, J., Beaudoin, C., & Sampalis, J. (2020). Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis. Drugs, 80( 7), 697-710. doi:10.1007/s40265-020-01296-x
NLM
Leclerc J, Thibault M, Midiani Gonella J, Beaudoin C, Sampalis J. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis [Internet]. Drugs. 2020 ; 80( 7): 697-710.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s40265-020-01296-x
Vancouver
Leclerc J, Thibault M, Midiani Gonella J, Beaudoin C, Sampalis J. Are generic drugs used in cardiology as effective and safe as their brand-name counterparts? A systematic review and meta-analysis [Internet]. Drugs. 2020 ; 80( 7): 697-710.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s40265-020-01296-x
Artigo de periodico
Adverse Effects of Immunosuppressant Drugs upon Airway Epithelial Cell and Mucociliary Clearance: Implications for Lung Transplant Recipients (2013)
Pazetti, Rogerio; Pêgo-Fernandes, Paulo Manuel; Jatene, Fabio Biscegli
Source: Drugs. Unidade: FM
Subjects: FIBROSE PULMONAR, TRANSPLANTE DE PULMÃO (COMPLICAÇÕES), CÉLULAS EPITELIAIS, FÁRMACOS IMUNOSSUPRESSORES (EFEITOS ADVERSOS), CITOCINAS, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAZETTI, Rogerio e PÊGO-FERNANDES, Paulo Manuel e JATENE, Fabio Biscegli. Adverse Effects of Immunosuppressant Drugs upon Airway Epithelial Cell and Mucociliary Clearance: Implications for Lung Transplant Recipients. Drugs, v. 73, n. 11, p. 1157-1169, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs40265-013-0089-0.pdf. Acesso em: 25 abr. 2026.
APA
Pazetti, R., Pêgo-Fernandes, P. M., & Jatene, F. B. (2013). Adverse Effects of Immunosuppressant Drugs upon Airway Epithelial Cell and Mucociliary Clearance: Implications for Lung Transplant Recipients. Drugs, 73( 11), 1157-1169. doi:10.1007/s40265-013-0089-0
NLM
Pazetti R, Pêgo-Fernandes PM, Jatene FB. Adverse Effects of Immunosuppressant Drugs upon Airway Epithelial Cell and Mucociliary Clearance: Implications for Lung Transplant Recipients [Internet]. Drugs. 2013 ; 73( 11): 1157-1169.[citado 2026 abr. 25 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs40265-013-0089-0.pdf
Vancouver
Pazetti R, Pêgo-Fernandes PM, Jatene FB. Adverse Effects of Immunosuppressant Drugs upon Airway Epithelial Cell and Mucociliary Clearance: Implications for Lung Transplant Recipients [Internet]. Drugs. 2013 ; 73( 11): 1157-1169.[citado 2026 abr. 25 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs40265-013-0089-0.pdf
Artigo de periodico
Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an extract-timi 25 analysis (2009)
Giraldez, Roberto R.; Wiviott, Stephen D.; Nicolau, José Carlos; Mohanavelu, Satishkumar; Morrow, David A.; Antman, Elliot M.; Giugliano, Roberto P.
Source: Drugs. Unidade: FM
Subjects: FIBRINA, ANTICOAGULANTES, ANÁLISE ESTATÍSTICA DE DADOS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIRALDEZ, Roberto R. et al. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an extract-timi 25 analysis. Drugs, v. 69, n. 11, p. 1433-1443, 2009Tradução . . Acesso em: 25 abr. 2026.
APA
Giraldez, R. R., Wiviott, S. D., Nicolau, J. C., Mohanavelu, S., Morrow, D. A., Antman, E. M., & Giugliano, R. P. (2009). Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an extract-timi 25 analysis. Drugs, 69( 11), 1433-1443.
NLM
Giraldez RR, Wiviott SD, Nicolau JC, Mohanavelu S, Morrow DA, Antman EM, Giugliano RP. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an extract-timi 25 analysis. Drugs. 2009 ; 69( 11): 1433-1443.[citado 2026 abr. 25 ]
Vancouver
Giraldez RR, Wiviott SD, Nicolau JC, Mohanavelu S, Morrow DA, Antman EM, Giugliano RP. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an extract-timi 25 analysis. Drugs. 2009 ; 69( 11): 1433-1443.[citado 2026 abr. 25 ]
Artigo de periodico
Role interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics (1993)
Ferreira, S. H.
Source: Drugs. Unidade: FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, S. H. Role interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs, v. 46, n. 1 , p. 1-9, 1993Tradução . . Acesso em: 25 abr. 2026.
APA
Ferreira, S. H. (1993). Role interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs, 46( 1 ), 1-9.
NLM
Ferreira SH. Role interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 1993 ;46( 1 ): 1-9.[citado 2026 abr. 25 ]
Vancouver
Ferreira SH. Role interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 1993 ;46( 1 ): 1-9.[citado 2026 abr. 25 ]
Artigo de periodico
Diuretics in cardiac oedema (1986)
Ramires, José Antônio Franchini; Pileggi, F
Source: Drugs. Unidade: FM
Assunto: CARDIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMIRES, José Antônio Franchini e PILEGGI, F. Diuretics in cardiac oedema. Drugs, v. 31, n. 4 suppl., p. 68-75, 1986Tradução . . Acesso em: 25 abr. 2026.
APA
Ramires, J. A. F., & Pileggi, F. (1986). Diuretics in cardiac oedema. Drugs, 31( 4 suppl.), 68-75.
NLM
Ramires JAF, Pileggi F. Diuretics in cardiac oedema. Drugs. 1986 ;31( 4 suppl.): 68-75.[citado 2026 abr. 25 ]
Vancouver
Ramires JAF, Pileggi F. Diuretics in cardiac oedema. Drugs. 1986 ;31( 4 suppl.): 68-75.[citado 2026 abr. 25 ]
Artigo de periodico
On the history of the development of inhibitors of angiotensin i conversion. In angiotensin converting enzyme inhibitors. In the proceedings of the symposium: treatment of hypertension and gongestiol heart failure. Brazil (1985)
Ferreira, S. H.
Source: Drugs. Unidade: FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, S. H. On the history of the development of inhibitors of angiotensin i conversion. In angiotensin converting enzyme inhibitors. In the proceedings of the symposium: treatment of hypertension and gongestiol heart failure. Brazil. Drugs, v. 30, p. 1-5, 1985Tradução . . Acesso em: 25 abr. 2026.
APA
Ferreira, S. H. (1985). On the history of the development of inhibitors of angiotensin i conversion. In angiotensin converting enzyme inhibitors. In the proceedings of the symposium: treatment of hypertension and gongestiol heart failure. Brazil. Drugs, 30, 1-5.
NLM
Ferreira SH. On the history of the development of inhibitors of angiotensin i conversion. In angiotensin converting enzyme inhibitors. In the proceedings of the symposium: treatment of hypertension and gongestiol heart failure. Brazil. Drugs. 1985 ;30 1-5.[citado 2026 abr. 25 ]
Vancouver
Ferreira SH. On the history of the development of inhibitors of angiotensin i conversion. In angiotensin converting enzyme inhibitors. In the proceedings of the symposium: treatment of hypertension and gongestiol heart failure. Brazil. Drugs. 1985 ;30 1-5.[citado 2026 abr. 25 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Indexado em